NUVB
Nuvation Bio Inc
5.70$
+0.4%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | 100.0% | 100.0% | |
| – | – | – | – | – | – | 89.9% | 13.4% | |
| – | – | – | – | – | – | 10.1% | 86.6% | |
| – | – | – | – | – | – | 6,658.1% | 183.0% | |
| – | – | – | – | – | – | 847.6% | 240.9% | |
| – | – | – | – | – | – | 7,537.4% | 425.3% | |
| – | – | – | – | – | – | -7,527.3% | -338.7% | |
| – | – | – | – | – | – | 4.3% | 21.8% | |
| – | – | – | – | – | – | -7,213.8% | -325.3% | |
| – | – | – | – | – | – | -7,213.8% | -325.3% | |
| – | – | – | – | – | – | -7,200.7% | -300.8% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.